Literature DB >> 2469931

Cloning of the rfb gene region of Shigella dysenteriae 1 and construction of an rfb-rfp gene cassette for the development of lipopolysaccharide-based live anti-dysentery vaccines.

S Sturm1, K N Timmis.   

Abstract

Recent studies have shown that determinants for the production of O antigen lipopolysaccharide in Shigella dysenteriae 1 are distributed over two distinct genetic elements, the chromosome and a 9 kb plasmid designated pHW400. In this communication, we describe the cloning of all determinants necessary for S. dysenteriae 1 O antigen production in E. coli K-12 and their combination in a single plasmid. An RP4::miniMu R-prime plasmid, R-prime 40, containing the his-rfb (histidine biosynthesis-lipopolysaccharide biosynthesis) gene region of the Shigella dysenteriae 1 chromosome was generated. E. coli K-12 bacteria containing R-prime 40 and pSS8, a transposon Tn5-tagged derivative of pHW400, produced lipopolysaccharide indistinguishable from that of S. dysenteriae 1. Small DNA fragments containing the rfb gene cluster and the rfp gene were subcloned from R-prime 40 and pSS8 and subsequently combined in vector pACYC184 to produce pSS37. This latter plasmid when introduced by transformation into E. coli K-12 provoked the formation of S. dysenteriae 1 O-specific lipopolysaccharide, a feature that suggests it may be useful in the construction of LPS-based live vaccines against the Shiga bacillus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2469931     DOI: 10.1016/0882-4010(86)90054-9

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  18 in total

1.  Pseudomonas aeruginosa B-band O-antigen chain length is modulated by Wzz (Ro1).

Authors:  L L Burrows; D Chow; J S Lam
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

Review 2.  Genetics of lipopolysaccharide biosynthesis in enteric bacteria.

Authors:  C A Schnaitman; J D Klena
Journal:  Microbiol Rev       Date:  1993-09

3.  Efficient incorporation of galactose into lipopolysaccharide by Escherichia coli K-12 strains with polar galE mutations.

Authors:  C A Schnaitman; E A Austin
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

4.  Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

Authors:  S R Klee; B D Tzschaschel; I Fält; A Kärnell; A A Lindberg; K N Timmis; C A Guzmán
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Glycoarrays with engineered phages displaying structurally diverse oligosaccharides enable high-throughput detection of glycan-protein interactions.

Authors:  Eda Çelik; Anne A Ollis; Yi Lasanajak; Adam C Fisher; Göksu Gür; David F Smith; Matthew P DeLisa
Journal:  Biotechnol J       Date:  2014-10-31       Impact factor: 4.677

6.  Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.

Authors:  I C Fält; E K Schweda; S Klee; M Singh; E Floderus; K N Timmis; A A Lindberg
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

7.  Role of Rfe and RfbF in the initiation of biosynthesis of D-galactan I, the lipopolysaccharide O antigen from Klebsiella pneumoniae serotype O1.

Authors:  B R Clarke; D Bronner; W J Keenleyside; W B Severn; J C Richards; C Whitfield
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

8.  Role of Escherichia coli K-12 rfa genes and the rfp gene of Shigella dysenteriae 1 in generation of lipopolysaccharide core heterogeneity and attachment of O antigen.

Authors:  J D Klena; R S Ashford; C A Schnaitman
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

9.  Acquisition of apparently intact and unmodified lipopolysaccharides from Escherichia coli by Bdellovibrio bacteriovorus.

Authors:  M A Stein; S A McAllister; B E Torian; D L Diedrich
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

10.  Superoxide dismutase and the resistance of Escherichia coli to phagocytic killing by human neutrophils.

Authors:  E Papp-Szabò; C L Sutherland; P D Josephy
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.